4597

Solasia Pharma K.K.
4597

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥8.72B
EV
¥7.67B
Shares Outstanding
218.05M
Beta
1.11

Wall Street View

Analyst Rating
BUY
Analyst Target Price
¥120.00
P/E 2025E
-
P/Revenue 2025E
3.81x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Solasia Pharma K.K.

gainify
4597

Solasia Pharma K.K.

4597

Solasia Pharma K.K. engages in the development and marketing of oncology drugs in Japan and other Asian countries. The company offers episil oral liquid for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and rad...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Arai, Yoshihiro

Employees

23

IPO Date

2017-03-27

Headquarters

Sumitomo Fudosan Shiba-Koen Tower, 4th Floor, 2-11-1, Shiba-koen, Minato-ku, Tokyo, Tokyo, 105-0011 Japan

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.